Table 2.
Comparison of clinical characteristics of head and neck cancer patients by race.
| Factors | European American (n = 24) | African American (n = 15) | P-value |
|---|---|---|---|
| Subsite | |||
| Oral Cavity | 67% | 55% | 0.77 |
| Oropharynx | 14% | 18% | |
| Larynx | 19% | 27% | |
| Missing | 4 | ||
| Clinical Stage | |||
| I | 30% | 7% | 0.22a |
| II | 22% | 43% | |
| III | 9% | 21% | |
| IV | 39% | 29% | |
| Missing | 1 | 1 | |
| Pathologic Stage | |||
| I | 45% | 23% | 0.56b |
| II | 14% | 15% | |
| III | 9% | 8% | |
| IV | 32% | 54% | |
| Missing | 2 | 2 | |
| HPV | |||
| Negative | 73% | 60% | 0.68 |
| Positive | 27% | 40% | |
| Missing/Unknown | 6 | 11 | |
| Time to Treatment(d) | |||
| Median (range) | 33 (20–42) | 55 (25–74) | 0.05 |
a
Fisher's test.
b
Wilcoxon Rank Sum test.